Literature DB >> 9398612

Human canalicular multispecific organic anion transporter (cMOAT) is expressed in human lung, gastric, and colorectal cancer cells.

F Narasaki1, M Oka, R Nakano, K Ikeda, M Fukuda, T Nakamura, H Soda, M Nakagawa, M Kuwano, S Kohno.   

Abstract

Human canalicular multispecific organic anion transporter (cMOAT), a glutathione conjugate membrane transporter, has been isolated from cisplatin-resistant cancer cells and is distributed mainly in normal liver. We analyzed the expression of human cMOAT in 14 lung, 11 gastric, and 9 colorectal non-drug-selected human cancer cells, two multidrug-resistant cells, and one cisplatin-resistant cells, using quantitative RT-PCR and newly developed anti-human cMOAT antibody. All cell lines analyzed here expressed human cMOAT at the level of mRNA and protein, and some of them expressed higher levels of human cMOAT than the cisplatin-resistant cells. The two multidrug-resistant cell lines co-expressed human cMOAT gene and both or either of MRP and MDR1 genes. Immunostaining showed that human cMOAT was predominantly localized to the cytoplasm of these single cells. Our results indicate that human cMOAT is expressed in various human cancer cells including drug-resistant cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398612     DOI: 10.1006/bbrc.1997.7703

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases.

Authors:  Zhe-Sheng Chen; Amit K Tiwari
Journal:  FEBS J       Date:  2011-08-01       Impact factor: 5.542

2.  Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.

Authors:  Shao-lin Ma; Ya-peng Hu; Fang Wang; Zhen-cong Huang; Yi-fan Chen; Xiao-kun Wang; Li-wu Fu
Journal:  Mol Med       Date:  2014-09-08       Impact factor: 6.354

3.  Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.

Authors:  Christopher M Mahaffey; Hongqiao Zhang; Alessandra Rinna; William Holland; Philip C Mack; Henry Jay Forman
Journal:  Free Radic Biol Med       Date:  2009-04-05       Impact factor: 7.376

4.  Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells.

Authors:  DE-Jun Tai; Wen-Sen Jin; Cheng-Si Wu; Hong-Wei Si; Xian-Dong Cao; Ai-Jun Guo; Jia-Cong Chang
Journal:  Exp Ther Med       Date:  2012-05-24       Impact factor: 2.447

Review 5.  Multidrug resistance associated proteins in multidrug resistance.

Authors:  Kamlesh Sodani; Atish Patel; Rishil J Kathawala; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2011-11-18

6.  Expression of MRP and cMOAT in childhood neuroblastomas and malignant liver tumors and its relevance to clinical behavior.

Authors:  T Matsunaga; H Shirasawa; T Hishiki; H Enomoto; K Kouchi; Y Ohtsuka; J Iwai; H Yoshida; M Tanabe; S Kobayashi; T Asano; T Etoh; Y Nishi; N Ohnuma
Journal:  Jpn J Cancer Res       Date:  1998-12

Review 7.  Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.

Authors:  Jose J G Marin; Maria J Monte; Rocio I R Macias; Marta R Romero; Elisa Herraez; Maitane Asensio; Sara Ortiz-Rivero; Candela Cives-Losada; Silvia Di Giacomo; Javier Gonzalez-Gallego; Jose L Mauriz; Thomas Efferth; Oscar Briz
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

8.  Effects of 3β-acethyl tormentic acid (3ATA) on ABCC proteins activity.

Authors:  Gleice Da Graça Rocha; Marisol Simões; Rodrigo Rodrigues Oliveira; Maria Auxiliadora Coelho Kaplan; Cerli Rocha Gattass
Journal:  Int J Mol Sci       Date:  2012-06-04       Impact factor: 6.208

9.  Expression of multidrug resistance-associated protein 2 in human gallbladder carcinoma.

Authors:  Hyun-Soo Kim; Nam Chul Kim; Kyu Hee Chae; Gun Kim; Won Seo Park; Yong-Koo Park; Youn Wha Kim
Journal:  Biomed Res Int       Date:  2013-06-16       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.